POZEN Logo
Print Page   Close Window

Press Release

POZEN CEO to Present at the 4th Annual Smith Barney Specialty Pharmaceutical Conference

CHAPEL HILL, N.C.--(BUSINESS WIRE)--Feb. 19, 2004--POZEN Inc. (NASDAQ: POZN) announced today that John R. Plachetka, Pharm.D., the Company's chairman, president and chief executive officer, will be speaking to investors at the 4th Annual Smith Barney Specialty Pharmaceutical Conference on Tuesday, February 24, at 8:00 a.m. Eastern Time in New York City.

Dr. Plachetka's presentation will be webcast live and archived on POZEN's home page at www.pozen.com.

Dr. Plachetka will also be presenting to investors at the NCINVEST 2004 Conference on Thursday, February 26, 2004 in Chapel Hill, N.C. The presentation will not be webcast.

POZEN is a pharmaceutical company developing therapeutic advancements in a cost effective manner. Product development efforts are focused on diseases with unmet medical needs where POZEN can improve efficacy, safety, and/or patient convenience. Since its inception, POZEN has developed the largest and most advanced product pipeline in the field of migraine. POZEN has development and commercial alliances with GlaxoSmithKline, Xcel Pharmaceuticals, and Nycomed. The company's common stock is traded on The Nasdaq Stock Market under the symbol "POZN". For detailed company information, including copies of this and other press releases, see POZEN's website: www.pozen.com.

CONTACT:
POZEN Inc.
Lisa Barthelemy, Director, Investor Relations
919-913-1044
John Barnhardt, Vice President, Finance and Administration
919-913-1030